{"id":4476,"date":"2022-01-13T02:25:27","date_gmt":"2022-01-13T02:25:27","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=4476"},"modified":"2023-08-29T17:52:34","modified_gmt":"2023-08-29T17:52:34","slug":"amplia-therapeutics-phase-2-pancreatic-cancer-trial-lead-drug-manufactured","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=4476","title":{"rendered":"\u5148\u5bfc\u836f\u7269\u751f\u4ea7\u5b8c\u6210\u540e\uff0cAmplia Therapeutics\u51c6\u5907\u8fdb\u884c\u80f0\u817a\u764c2\u671f\u4e34\u5e8a\u8bd5\u9a8c"},"content":{"rendered":"<p>\u65e5\u524d\uff0cAmplia Therapeutics (ASX: ATX)\u5b8c\u6210\u4e86\u5c40\u7076\u9ecf\u9644\u6fc0\u9176(FAK)\u6291\u5236\u5242\u836f\u7269AMP945\u7684\u751f\u4ea7\uff0c\u79bb\u80f0\u817a\u764c\u548c\u80ba\u7ea4\u7ef4\u5316\u76842\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u7684\u627f\u5305\u5546\u5728\u9884\u7b97\u8303\u56f4\u5185\u6309\u65f6\u5b8c\u6210\u4e862\u516c\u65a4AMP945\u7684GMP\u8fd0\u884c\u3002<\/p>\n<p>Amplia\u6307\u51fa\uff0c\u4e4b\u524d\u7684\u6279\u6b21\u5c3a\u5bf8\u4e3a1kg\uff0c\u8fd9\u610f\u5473\u7740\u751f\u4ea7\u89c4\u6a21\u5df2\u7ecf\u7ffb\u4e86\u4e00\u756a\uff0c\u540c\u65f6\u7b26\u5408GMP\u6761\u4ef6\u3002<\/p>\n<p>Amplia\u9996\u5e2d\u6267\u884c\u5b98John Lambert\u535a\u58eb\u8868\u793a:\u201cAMP945\u4e34\u5e8a\u7ea7\u7684\u751f\u4ea7\u80fd\u529b\u6210\u529f\u589e\u52a0\u4e86\u4e00\u500d\uff0c\u5e76\u5b9e\u65bd\u4e86\u751f\u4ea7\u6539\u8fdb\uff0c\u8fd9\u662f\u6770\u51fa\u7684\u6210\u679c\uff0c\u8d85\u51fa\u4e86\u6211\u4eec\u6700\u521d\u7684\u9884\u671f\u3002\u201d<\/p>\n<p>\u4ed6\u8865\u5145\u8bf4:\u201c\u8fd9\u4e9b\u6539\u8fdb\u4e0d\u4ec5\u4e3a\u6211\u4eec\u7684\u8fd1\u671f\u5f00\u53d1\u9879\u76ee\u63d0\u4f9b\u4e86\u6750\u6599\uff0c\u800c\u4e14\u4e3aAPM945\u6570\u636e\u5305\u5960\u5b9a\u4e86\u575a\u5b9e\u7684\u57fa\u7840\uff0c\u8fd9\u5c06\u662f\u672a\u6765\u76d1\u7ba1\u5e94\u7528\u53ca\u5176\u5546\u4e1a\u53d1\u5c55\u6240\u5fc5\u9700\u7684\u3002\u201d<\/p>\n<h2>FAK\u6291\u5236\u5242<\/h2>\n<p>\u6839\u636eAmplia\u7684\u7814\u7a76\uff0cFAK\u4e0e\u8bb8\u591a\u764c\u75c7\u9632\u5fa1\u673a\u5236\u6709\u5173\uff0c\u8fd9\u4e9b\u673a\u5236\u53ef\u4ee5\u964d\u4f4e\u6297\u764c\u6cbb\u7597\u7684\u6548\u679c\u3002<\/p>\n<p>\u764c\u75c7\u4e2dFAK\u6c34\u5e73\u9ad8\u901a\u5e38\u4e0e\u4e0d\u826f\u7ed3\u679c\u6709\u5173\u3002<\/p>\n<p>Amplia\u5f00\u53d1\u4e86AMP945\uff0c\u8fd9\u662f\u4e00\u79cdFAK\u6291\u5236\u5242\uff0c\u53ef\u4ee5\u7834\u574f\u764c\u75c7\u9632\u5fa1\uff0c\u4f7f\u75be\u75c5\u5bf9\u5316\u7597\u548c\u5176\u4ed6\u836f\u7269\u6cbb\u7597\u66f4\u6709\u53cd\u5e94\u3002<\/p>\n<h2>\u672c\u5b63\u5ea6\u5f00\u59cb\u7b2c\u4e8c\u9636\u6bb5\u8bd5\u9a8c<\/h2>\n<p>Amplia\u5c06\u5728\u5176\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u4f7f\u7528AMP945\u6cbb\u7597\u80f0\u817a\u764c\u60a3\u8005\u3002\u5ba1\u5224\u5c06\u4e8e\u672c\u5b63\u5ea6\u5f00\u59cb\u3002<\/p>\n<p>\u5728\u5373\u5c06\u8fdb\u884c\u7684\u8bd5\u9a8c\u4e2d\uff0cAMP945\u5c06\u4e0e\u5316\u7597\u836f\u7269\u5409\u897f\u4ed6\u6ee8\u548cAbraxane\u8054\u5408\u4f7f\u7528\u3002\u5409\u897f\u4ed6\u6ee8\u548cAbraxane\u662f\u76ee\u524d\u65b0\u8bca\u65ad\u80f0\u817a\u764c\u60a3\u8005\u7684\u62a4\u7406\u6807\u51c6\u3002<\/p>\n<p>\u80f0\u817a\u764c\u662f\u6700\u81f4\u547d\u7684\u6076\u6027\u80bf\u7624\u4e4b\u4e00\uff0c5\u5e74\u751f\u5b58\u7387\u4e3a5-10%\u3002<\/p>\n<p>\u9664\u4e86\u80f0\u817a\u764c\u8bd5\u9a8c\uff0cAmplia\u8fd8\u5c06\u5728\u7ea4\u7ef4\u5316\u80ba\u75c5\u60a3\u8005\u4e2d\u5f00\u5c55AMP945\u7814\u7a76\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u5c06\u4e8e\u4e0b\u6708\u5f00\u59cb\u4e3a\u671f\u4e09\u4e2a\u6708\u7684\u5ef6\u957f\u6bd2\u7406\u5b66\u7814\u7a76\uff0c\u8fd9\u5c06\u7528\u4e8e\u652f\u6301\u8bd5\u9a8c\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u65e5\u524d\uff0cAmplia Therapeutics (ASX: ATX)\u5b8c\u6210\u4e86\u5c40\u7076\u9ecf\u9644\u6fc0\u9176(FAK)\u6291\u5236\u5242\u836f\u7269AMP945\u7684\u751f\u4ea7\uff0c\u79bb\u80f0\u817a\u764c\u548c\u80ba\u7ea4\u7ef4\u5316\u76842\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002 \u8be5\u516c\u53f8\u7684\u627f\u5305\u5546\u5728\u9884\u7b97\u8303\u56f4\u5185\u6309\u65f6\u5b8c\u6210\u4e862\u516c\u65a4AMP945\u7684GMP\u8fd0\u884c\u3002 Amplia\u6307\u51fa\uff0c\u4e4b\u524d\u7684\u6279\u6b21\u5c3a\u5bf8\u4e3a1kg\uff0c\u8fd9\u610f\u5473\u7740\u751f\u4ea7\u89c4\u6a21\u5df2\u7ecf\u7ffb\u4e86\u4e00\u756a\uff0c\u540c\u65f6\u7b26\u5408GMP\u6761\u4ef6\u3002 Amplia\u9996\u5e2d\u6267\u884c\u5b98John Lambert\u535a\u58eb\u8868\u793a:\u201cAMP945\u4e34\u5e8a\u7ea7\u7684\u751f\u4ea7\u80fd\u529b\u6210\u529f\u589e\u52a0\u4e86\u4e00\u500d\uff0c\u5e76\u5b9e\u65bd\u4e86\u751f\u4ea7\u6539\u8fdb\uff0c\u8fd9\u662f\u6770\u51fa\u7684\u6210\u679c\uff0c\u8d85\u51fa\u4e86\u6211\u4eec\u6700\u521d\u7684\u9884\u671f\u3002\u201d \u4ed6\u8865\u5145\u8bf4:\u201c\u8fd9\u4e9b\u6539\u8fdb\u4e0d\u4ec5\u4e3a\u6211\u4eec\u7684\u8fd1\u671f\u5f00\u53d1\u9879\u76ee\u63d0\u4f9b\u4e86\u6750\u6599\uff0c\u800c\u4e14\u4e3aAPM945\u6570\u636e\u5305\u5960\u5b9a\u4e86\u575a\u5b9e\u7684\u57fa\u7840\uff0c\u8fd9\u5c06\u662f\u672a\u6765\u76d1\u7ba1\u5e94\u7528\u53ca\u5176\u5546\u4e1a\u53d1\u5c55\u6240\u5fc5\u9700\u7684\u3002\u201d FAK\u6291\u5236\u5242 \u6839\u636eAmplia\u7684\u7814\u7a76\uff0cFAK\u4e0e\u8bb8\u591a\u764c\u75c7\u9632\u5fa1\u673a\u5236\u6709\u5173\uff0c\u8fd9\u4e9b\u673a\u5236\u53ef\u4ee5\u964d\u4f4e\u6297\u764c\u6cbb\u7597\u7684\u6548\u679c\u3002 \u764c\u75c7\u4e2dFAK\u6c34\u5e73\u9ad8\u901a\u5e38\u4e0e\u4e0d\u826f\u7ed3\u679c\u6709\u5173\u3002 Amplia\u5f00\u53d1\u4e86AMP945\uff0c\u8fd9\u662f\u4e00\u79cdFAK\u6291\u5236\u5242\uff0c\u53ef\u4ee5\u7834\u574f\u764c\u75c7\u9632\u5fa1\uff0c\u4f7f\u75be\u75c5\u5bf9\u5316\u7597\u548c\u5176\u4ed6\u836f\u7269\u6cbb\u7597\u66f4\u6709\u53cd\u5e94\u3002 \u672c\u5b63\u5ea6\u5f00\u59cb\u7b2c\u4e8c\u9636\u6bb5\u8bd5\u9a8c Amplia\u5c06\u5728\u5176\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u4f7f\u7528AMP945\u6cbb\u7597\u80f0\u817a\u764c\u60a3\u8005\u3002\u5ba1\u5224\u5c06\u4e8e\u672c\u5b63\u5ea6\u5f00\u59cb\u3002 \u5728\u5373\u5c06\u8fdb\u884c\u7684\u8bd5\u9a8c\u4e2d\uff0cAMP945\u5c06\u4e0e\u5316\u7597\u836f\u7269\u5409\u897f\u4ed6\u6ee8\u548cAbraxane\u8054\u5408\u4f7f\u7528\u3002\u5409\u897f\u4ed6\u6ee8\u548cAbraxane\u662f\u76ee\u524d\u65b0\u8bca\u65ad\u80f0\u817a\u764c\u60a3\u8005\u7684\u62a4\u7406\u6807\u51c6\u3002 \u80f0\u817a\u764c\u662f\u6700\u81f4\u547d\u7684\u6076\u6027\u80bf\u7624\u4e4b\u4e00\uff0c5\u5e74\u751f\u5b58\u7387\u4e3a5-10%\u3002 \u9664\u4e86\u80f0\u817a\u764c\u8bd5\u9a8c\uff0cAmplia\u8fd8\u5c06\u5728\u7ea4\u7ef4\u5316\u80ba\u75c5\u60a3\u8005\u4e2d\u5f00\u5c55AMP945\u7814\u7a76\u3002 \u8be5\u516c\u53f8\u5c06\u4e8e\u4e0b\u6708\u5f00\u59cb\u4e3a\u671f\u4e09\u4e2a\u6708\u7684\u5ef6\u957f\u6bd2\u7406\u5b66\u7814\u7a76\uff0c\u8fd9\u5c06\u7528\u4e8e\u652f\u6301\u8bd5\u9a8c\u3002<\/p>\n","protected":false},"author":3,"featured_media":18926,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[58],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u5148\u5bfc\u836f\u7269\u751f\u4ea7\u5b8c\u6210\u540e\uff0cAmplia Therapeutics\u51c6\u5907\u8fdb\u884c\u80f0\u817a\u764c2\u671f\u4e34\u5e8a\u8bd5\u9a8c<\/title>\n<meta name=\"description\" content=\"\u65e5\u524d\uff0cAmplia Therapeutics (ASX: ATX)\u5b8c\u6210\u4e86\u5c40\u7076\u9ecf\u9644\u6fc0\u9176(FAK)\u6291\u5236\u5242\u836f\u7269AMP945\u7684\u751f\u4ea7\uff0c\u79bb\u80f0\u817a\u764c\u548c\u80ba\u7ea4\u7ef4\u5316\u76842\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u5148\u5bfc\u836f\u7269\u751f\u4ea7\u5b8c\u6210\u540e\uff0cAmplia Therapeutics\u51c6\u5907\u8fdb\u884c\u80f0\u817a\u764c2\u671f\u4e34\u5e8a\u8bd5\u9a8c\" \/>\n<meta property=\"og:description\" content=\"\u65e5\u524d\uff0cAmplia Therapeutics (ASX: ATX)\u5b8c\u6210\u4e86\u5c40\u7076\u9ecf\u9644\u6fc0\u9176(FAK)\u6291\u5236\u5242\u836f\u7269AMP945\u7684\u751f\u4ea7\uff0c\u79bb\u80f0\u817a\u764c\u548c\u80ba\u7ea4\u7ef4\u5316\u76842\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-phase-2-pancreatic-cancer-trial-lead-drug-manufactured\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-13T02:25:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:52:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Amplia-Therapeutics-ASX-ATX-AMP945-toxicology-studies-Phase-2-clinical-trials-pancreatic-cancer-lung-fibrosis.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-phase-2-pancreatic-cancer-trial-lead-drug-manufactured\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-phase-2-pancreatic-cancer-trial-lead-drug-manufactured\/\",\"name\":\"\u5148\u5bfc\u836f\u7269\u751f\u4ea7\u5b8c\u6210\u540e\uff0cAmplia Therapeutics\u51c6\u5907\u8fdb\u884c\u80f0\u817a\u764c2\u671f\u4e34\u5e8a\u8bd5\u9a8c\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2022-01-13T02:25:27+00:00\",\"dateModified\":\"2023-08-29T17:52:34+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"\u65e5\u524d\uff0cAmplia Therapeutics (ASX: ATX)\u5b8c\u6210\u4e86\u5c40\u7076\u9ecf\u9644\u6fc0\u9176(FAK)\u6291\u5236\u5242\u836f\u7269AMP945\u7684\u751f\u4ea7\uff0c\u79bb\u80f0\u817a\u764c\u548c\u80ba\u7ea4\u7ef4\u5316\u76842\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-phase-2-pancreatic-cancer-trial-lead-drug-manufactured\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-phase-2-pancreatic-cancer-trial-lead-drug-manufactured\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-phase-2-pancreatic-cancer-trial-lead-drug-manufactured\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u5148\u5bfc\u836f\u7269\u751f\u4ea7\u5b8c\u6210\u540e\uff0cAmplia Therapeutics\u51c6\u5907\u8fdb\u884c\u80f0\u817a\u764c2\u671f\u4e34\u5e8a\u8bd5\u9a8c\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u5148\u5bfc\u836f\u7269\u751f\u4ea7\u5b8c\u6210\u540e\uff0cAmplia Therapeutics\u51c6\u5907\u8fdb\u884c\u80f0\u817a\u764c2\u671f\u4e34\u5e8a\u8bd5\u9a8c","description":"\u65e5\u524d\uff0cAmplia Therapeutics (ASX: ATX)\u5b8c\u6210\u4e86\u5c40\u7076\u9ecf\u9644\u6fc0\u9176(FAK)\u6291\u5236\u5242\u836f\u7269AMP945\u7684\u751f\u4ea7\uff0c\u79bb\u80f0\u817a\u764c\u548c\u80ba\u7ea4\u7ef4\u5316\u76842\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"\u5148\u5bfc\u836f\u7269\u751f\u4ea7\u5b8c\u6210\u540e\uff0cAmplia Therapeutics\u51c6\u5907\u8fdb\u884c\u80f0\u817a\u764c2\u671f\u4e34\u5e8a\u8bd5\u9a8c","og_description":"\u65e5\u524d\uff0cAmplia Therapeutics (ASX: ATX)\u5b8c\u6210\u4e86\u5c40\u7076\u9ecf\u9644\u6fc0\u9176(FAK)\u6291\u5236\u5242\u836f\u7269AMP945\u7684\u751f\u4ea7\uff0c\u79bb\u80f0\u817a\u764c\u548c\u80ba\u7ea4\u7ef4\u5316\u76842\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-phase-2-pancreatic-cancer-trial-lead-drug-manufactured\/","og_site_name":"smallcapsCN","article_published_time":"2022-01-13T02:25:27+00:00","article_modified_time":"2023-08-29T17:52:34+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Amplia-Therapeutics-ASX-ATX-AMP945-toxicology-studies-Phase-2-clinical-trials-pancreatic-cancer-lung-fibrosis.jpg","type":"image\/jpeg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-phase-2-pancreatic-cancer-trial-lead-drug-manufactured\/","url":"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-phase-2-pancreatic-cancer-trial-lead-drug-manufactured\/","name":"\u5148\u5bfc\u836f\u7269\u751f\u4ea7\u5b8c\u6210\u540e\uff0cAmplia Therapeutics\u51c6\u5907\u8fdb\u884c\u80f0\u817a\u764c2\u671f\u4e34\u5e8a\u8bd5\u9a8c","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2022-01-13T02:25:27+00:00","dateModified":"2023-08-29T17:52:34+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"\u65e5\u524d\uff0cAmplia Therapeutics (ASX: ATX)\u5b8c\u6210\u4e86\u5c40\u7076\u9ecf\u9644\u6fc0\u9176(FAK)\u6291\u5236\u5242\u836f\u7269AMP945\u7684\u751f\u4ea7\uff0c\u79bb\u80f0\u817a\u764c\u548c\u80ba\u7ea4\u7ef4\u5316\u76842\u671f\u4e34\u5e8a\u8bd5\u9a8c\u53c8\u8fd1\u4e86\u4e00\u6b65\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-phase-2-pancreatic-cancer-trial-lead-drug-manufactured\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-phase-2-pancreatic-cancer-trial-lead-drug-manufactured\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-phase-2-pancreatic-cancer-trial-lead-drug-manufactured\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"\u5148\u5bfc\u836f\u7269\u751f\u4ea7\u5b8c\u6210\u540e\uff0cAmplia Therapeutics\u51c6\u5907\u8fdb\u884c\u80f0\u817a\u764c2\u671f\u4e34\u5e8a\u8bd5\u9a8c"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4476"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4476"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4476\/revisions"}],"predecessor-version":[{"id":14355,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4476\/revisions\/14355"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/18926"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4476"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4476"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4476"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}